NCT04899739Completed
Intraoperative Endoscopic Ultrasound for Pancreatic Cancer
Prospective Study of Preoperative Diagnostic Endoscopy for the Diagnosis of Occult Metastatic Lesions of Operable Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
Nowadays pancreatic cancer is one of the deadliest oncological pathologies. The only effective curative tool is the surgery. Before the intervention, an endoscopic ultrasound is performed on the patient to carry out the biopsy of the main tumor. In this study, the echoendoscopie will be extended to lymph node staging away from the surgical field in order to implement a simple classification of lymph nodes, based on non-invasive ultrasound criteria. This would facilitate the location and qualification of peripancreatic lymph nodes and distant from the tumor, and therefore the staging of the tumor.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 21 May 2021
- Start date
- 5 Dec 2021
- Primary completion date
- 4 Jun 2025
- Lead sponsor
- IHU Strasbourg
- Diseases
- Pancreatic cancer
- NCT number
- NCT04899739
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 5 Dec 2021 to the primary completion date, 4 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient in exclusion period (determined by a previous study or in progress)
Other illness
- Patient carrying a right-left shunt, a severe pulmonary arterial hypertension (high blood pressure pulmonary\> 90 mm Hg), uncontrolled systemic hypertension or suffering from respiratory distress syndrome.
Lab values
- Patient presenting with bleeding disease with disorder hemostasis and coagulation (PT \<60%, TCA\> 40 s and platelets \<60,000 / mm3)
Other
- Patient on anticoagulant or antiaggregant treatment that cannot be temporarily interrupted
- Pregnant or breastfeeding patient
- Patient under legal protection
- Patient under guardianship or trusteeship
Who the study is looking for
- Patient over 18 years old
- Patient with a solid or degenerated cystic tumor of the pancreas requiring curative surgery
- Patient with a complete clinical examination performed
- Patient with no contraindication to anesthesia, upper digestive endoscopy and pancreatic surgery
- Patient able to receive and understand information relating to the study and give informed written consent
- Patient affiliated to the French social security system
Age in the registry: 18 years to 95 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Service de Chirurgie Digestive et Endocrinienne Coordinator of this site? Confirm its status | Strasbourg | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.